NCT02285985View on ClinicalTrials.gov

Effects of Saxagliptin on Adipose Tissue Inflammation in Humans

PHASE4CompletedINTERVENTIONAL

Enrollment

103

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 12, 2019

Study Completion Date

October 12, 2019

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG

Saxagliptin

Tablets: 5 mg

DRUG

Placebo

Tablets: 5mg

Trial Locations (1)

85012

Carl T. Hayden VA Medical Hospital, Phoenix

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Phoenix VA Health Care System

FED

NCT02285985 - Effects of Saxagliptin on Adipose Tissue Inflammation in Humans | Biotech Hunter | Biotech Hunter